These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

401 related articles for article (PubMed ID: 8080724)

  • 21. Evaluation of trans-tetrachloro-1,2-diaminocyclohexane platinum (IV) in murine leukemia L1210 resistant and sensitive to cis-diamminedichloroplatinum (II).
    Wilkoff LJ; Dulmadge EA; Trader MW; Harrison SD; Griswold DP
    Cancer Chemother Pharmacol; 1987; 20(2):96-100. PubMed ID: 3664938
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Platinum coordination complexes which circumvent cisplatin resistance.
    Harrap KR; Kelland LR; Jones M; Goddard PM; Orr RM; Morgan SE; Murrer BA; Abrams MJ; Giandomenico CM; Cobbleigh T
    Adv Enzyme Regul; 1991; 31():31-43. PubMed ID: 1877393
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ammine/amine platinum (II) complexes effective in vivo against murine tumors sensitive or resistant to cisplatin and tetraplatin.
    Siddik ZH; Thai G; Yoshida M; Zhang YP; Khokhar AR
    J Cancer Res Clin Oncol; 1994; 120(10):571-7. PubMed ID: 7929527
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cytotoxicity, cellular uptake and DNA binding of the novel trinuclear platinun complex BBR 3464 in sensitive and cisplatin resistant murine leukemia cells.
    Di Blasi P; Bernareggi A; Beggiolin G; Piazzoni L; Menta E; Formento ML
    Anticancer Res; 1998; 18(4C):3113-7. PubMed ID: 9713519
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A novel trans-platinum coordination complex possessing in vitro and in vivo antitumor activity.
    Kelland LR; Barnard CF; Mellish KJ; Jones M; Goddard PM; Valenti M; Bryant A; Murrer BA; Harrap KR
    Cancer Res; 1994 Nov; 54(21):5618-22. PubMed ID: 7923207
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Glutathione-mediated modulation of tetraplatin activity against sensitive and resistant tumor cells.
    Kido Y; Khokhar AR; Siddik ZH
    Biochem Pharmacol; 1994 Apr; 47(9):1635-42. PubMed ID: 8185678
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cellular pharmacology of cis and trans pairs of platinum complexes in cisplatin-sensitive and -resistant human ovarian carcinoma cells.
    O'Neill CF; Hunakova L; Kelland LR
    Chem Biol Interact; 1999 Nov; 123(1):11-29. PubMed ID: 10597899
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Circumvention of acquired tetraplatin resistance in a human ovarian carcinoma cell line by a novel trans platinum complex, JM335 [trans ammine (cyclohexylamine) dichloro dihydroxo platinum (IV)].
    Mellish KJ; Barnard CF; Kelland LR; Harrap KR
    Int J Cancer; 1994 Oct; 59(1):65-70. PubMed ID: 7927906
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of DNA replication in carrier-ligand-specific resistance to platinum compounds in L1210 cells.
    Gibbons GR; Kaufmann WK; Chaney SG
    Carcinogenesis; 1991 Dec; 12(12):2253-7. PubMed ID: 1747924
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sensitivity to novel platinum compounds of panels of human lung cancer cell lines with acquired and inherent resistance to cisplatin.
    Twentyman PR; Wright KA; Mistry P; Kelland LR; Murrer BA
    Cancer Res; 1992 Oct; 52(20):5674-80. PubMed ID: 1327513
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cytotoxicity and tolerance to DNA adducts of alicyclic mixed amine platinum(II) homologs in tumor models sensitive and resistant to cisplatin or tetraplatin.
    Yoshida M; Khokhar AR; Siddik ZH
    Oncol Rep; 1998; 5(5):1281-7. PubMed ID: 9683851
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Modulatory effect of axial and equatorial ligands on antitumor activities of trans-1R,2R-diaminocyclohexane platinum(IV) complexes.
    Siddik ZH; al-Baker S; Thai G; Khokhar AR
    Anticancer Drug Des; 1994 Apr; 9(2):139-51. PubMed ID: 8166929
    [TBL] [Abstract][Full Text] [Related]  

  • 33. cis-Amminedichloro(2-methylpyridine) platinum(II) (AMD473), a novel sterically hindered platinum complex: in vivo activity, toxicology, and pharmacokinetics in mice.
    Raynaud FI; Boxall FE; Goddard PM; Valenti M; Jones M; Murrer BA; Abrams M; Kelland LR
    Clin Cancer Res; 1997 Nov; 3(11):2063-74. PubMed ID: 9815598
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Therapeutic and pharmacological studies of tetrachloro(d,l-trans)1,2-diaminocyclohexane platinum (IV) (tetraplatin), a new platinum analogue.
    Rahman A; Roh JK; Wolpert-DeFilippes MK; Goldin A; Venditti JM; Woolley PV
    Cancer Res; 1988 Apr; 48(7):1745-52. PubMed ID: 3162402
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthesis and antitumor activity of a series of [2-substituted-4,5-bis(aminomethyl)-1,3-dioxolane]platinum(II) complexes.
    Kim DK; Kim G; Gam J; Cho YB; Kim HT; Tai JH; Kim KH; Hong WS; Park JG
    J Med Chem; 1994 May; 37(10):1471-85. PubMed ID: 8182706
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The role of glutathione (GSH) in determining sensitivity to platinum drugs in vivo in platinum-sensitive and -resistant murine leukaemia and plasmacytoma and human ovarian carcinoma xenografts.
    Goddard P; Valenti M; Kelland LR
    Anticancer Res; 1994; 14(3A):1065-70. PubMed ID: 8074451
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro circumvention of cisplatin resistance by the novel sterically hindered platinum complex AMD473.
    Holford J; Sharp SY; Murrer BA; Abrams M; Kelland LR
    Br J Cancer; 1998; 77(3):366-73. PubMed ID: 9472630
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transport of cisplatin and bis-acetato-ammine-dichlorocyclohexylamine Platinum(IV) (JM216) in human ovarian carcinoma cell lines: identification of a plasma membrane protein associated with cisplatin resistance.
    Sharp SY; Rogers PM; Kelland LR
    Clin Cancer Res; 1995 Sep; 1(9):981-9. PubMed ID: 9816070
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of murine tumour models and their acquired platinum-resistant counterparts in the evaluation of novel platinum antitumour agents: a cautionary note.
    Goddard PM; Valenti MR; Harrap KR
    Ann Oncol; 1991 Sep; 2(8):535-40. PubMed ID: 1793720
    [TBL] [Abstract][Full Text] [Related]  

  • 40. DNA-binding properties of novel cis- and trans platinum-based anticancer agents in 2 human ovarian carcinoma cell lines.
    Mellish KJ; Barnard CF; Murrer BA; Kelland LR
    Int J Cancer; 1995 Sep; 62(6):717-23. PubMed ID: 7558420
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.